Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Niger
Niger: Yellow fever vaccine (YFV) immunization coverage among 1-year olds was 82.0% in 2025. ▲ Rising
Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Niger, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for yellow fever vaccine (yfv) immunization coverage among 1-year olds in Niger is 82.0%, measured in 2025.
Compared with earlier readings it is up 1.2% on the previous year and down 2.4% over ten years.
Over the whole period, yellow fever vaccine (yfv) immunization coverage among 1-year olds in Niger peaked at 84.0% in 2015 and was at its lowest, 10.0%, in 2000.
Niger ranks 11th of 45 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 10.0% | — |
| 2001 | 15.0% | +50.0% |
| 2002 | 21.0% | +40.0% |
| 2003 | 26.0% | +23.8% |
| 2004 | 32.0% | +23.1% |
| 2005 | 37.0% | +15.6% |
| 2006 | 32.0% | -13.5% |
| 2007 | 32.0% | +0.0% |
| 2008 | 47.0% | +46.9% |
| 2009 | 67.0% | +42.6% |
| 2010 | 64.0% | -4.5% |
| 2011 | 52.0% | -18.8% |
| 2012 | 73.0% | +40.4% |
| 2013 | 75.0% | +2.7% |
| 2014 | 79.0% | +5.3% |
| 2015 | 84.0% | +6.3% |
| 2016 | 76.0% | -9.5% |
| 2017 | 82.0% | +7.9% |
| 2018 | 78.0% | -4.9% |
| 2019 | 83.0% | +6.4% |
| 2020 | 67.0% | -19.3% |
| 2021 | 80.0% | +19.4% |
| 2022 | 80.0% | +0.0% |
| 2023 | 80.0% | +0.0% |
| 2024 | 81.0% | +1.2% |
| 2025 | 82.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 31.9% | 10.0% | 67.0% | 10 |
| 2010s | 74.6% | 52.0% | 84.0% | 10 |
| 2020s | 78.3% | 67.0% | 82.0% | 6 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Population ages 75-79, female, annual growth rate 1.39 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0024 units per person (2025)
- Population ages 75-79, male, annual growth rate 6.37 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0019 units per person (2025)
Frequently asked questions
- What is yellow fever vaccine (yfv) immunization coverage among 1-year olds in Niger?
- Yellow fever vaccine (yfv) immunization coverage among 1-year olds in Niger was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest yellow fever vaccine (yfv) immunization coverage among 1-year olds recorded in Niger?
- The highest recorded value was 84.0% in 2015.
- What is the lowest yellow fever vaccine (yfv) immunization coverage among 1-year olds recorded in Niger?
- The lowest recorded value was 10.0% in 2000.
- How does Niger rank for yellow fever vaccine (yfv) immunization coverage among 1-year olds?
- Niger ranks 11th out of 45 countries with data for 2025.
- Is yellow fever vaccine (yfv) immunization coverage among 1-year olds rising or falling in Niger?
- Over the last ten years it is down 2.4%. The long-run trend across the full record is rising.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Yellow fever vaccine (YFV) immunization coverage among 1-year olds (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).